Dr Stephanie Kaye-Barrett
Medical Director, Chelsea Rheumatology Clinic, Trustee of the Royal Society of Medicine
Register to join Episode 47 'Treating severe cases and the inflammatory response' on Zoom here.
In the most severe cases of COVID-19, the virus causes an aggressive autoinflammatory response, also known as the cytokine storm, which causes the body to attack itself, sometimes leading to lifelong organ impairment or death. The other problems associated with this overactive immune response are vascular, with the production of major multiple blood clots.
This webinar will cover how to analyse data from blood tests to guide immune treatments such as corticosteroids, and how cytokine pathway blockers are being used to calm the deadly cytokine storm and its consequences.
Professor David Isenberg, Academic Director of the UCL Centre for Rheumatology, will speak to Dr Stephanie Kaye-Barrett, Medical Director at the Chelsea Rheumatology Clinic, about these treatments - many of which have been used in rheumatology for years - and how they can be used to combat the complications caused by the virus.
Register for this free webinar on Zoom.
Join in the conversation online using #RSMLive
Follow us on Twitter: @RoySocMed
Medical Director, Chelsea Rheumatology Clinic, Trustee of the Royal Society of Medicine
Academic Director, UCL Centre for Rheumatology
Online
Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s COVID-19 online events are available free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.